Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.47 |
| ▸ | PKM | P14618 | 2/20 | 0.47 |
| ▸ | THRB | P10828 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
| ▸ | DGKA | P23743 | 1/20 | 0.37 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.37 |
| ▸ | PPARG | P37231 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11068420 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL11001712 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL21046041 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL11063113 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL183166 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL7516454 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL8216269 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL7516322 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL11065218 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 | |
| SCHEMBL7505385 | 0.90 | MEN1 (0.59) | MEN1KMT2AMAPTATML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8822635-B2 | Selenium-based monomers and conjugated polymers, methods of making, and use thereof | THE UNIVERSITY OF CONNECTICUT (US) | 2014-09-02 | — | — | US | disclosed |
| US-20130289286-A1 | SELENIUM-BASED MONOMERS AND CONJUGATED POLYMERS, METHODS OF MAKING, AND USE THEREOF | THE UNIVERSITY OF CONNECTICUT (US) | 2013-10-31 | — | — | US | disclosed |
| US-8513377-B2 | Selenium-based monomers and conjugated polymers, methods of making, and use thereof | THE UNIVERSITY OF CONNECTICUT (US) | 2013-08-20 | — | — | US | disclosed |
| US-20120226015-A1 | SELENIUM-BASED MONOMERS AND CONJUGATED POLYMERS, METHODS OF MAKING, AND USE THEREOF | THE UNIVERSITY OF CONNECTICUT | 2012-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120226015-A1 | SELENIUM-BASED MONOMERS AND CONJUGATED POLYMERS, METHODS OF MAKING, AND USE THEREOF | SELENOI, SCLY, GPX4 | MEN1 285/4885KMT2A 2137/4885MAPT 1076/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.